BR0110184A - Derivado de piridina-1-óxido, e processo para a sua transformação em compostos farmaceuticamente eficazes - Google Patents

Derivado de piridina-1-óxido, e processo para a sua transformação em compostos farmaceuticamente eficazes

Info

Publication number
BR0110184A
BR0110184A BR0110184-6A BR0110184A BR0110184A BR 0110184 A BR0110184 A BR 0110184A BR 0110184 A BR0110184 A BR 0110184A BR 0110184 A BR0110184 A BR 0110184A
Authority
BR
Brazil
Prior art keywords
pyridine
oxide
transformation
piperidinyl
propoxy
Prior art date
Application number
BR0110184-6A
Other languages
English (en)
Other versions
BRPI0110184B8 (pt
BRPI0110184B1 (pt
Inventor
Laszlo Uroegi
Zita Jegesne Csakai
Lajos Gruber
Laszlo Itvoes
Jozsef Toth
Istvan Toemoeskoezi
Aniko Szakacsne Schmidt
Ferencne Reider
Maria Schneiderne Barlay
Original Assignee
Biorex Kutato Fejlesztoe Kft
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Biorex Kutato Fejlesztoe Kft filed Critical Biorex Kutato Fejlesztoe Kft
Publication of BR0110184A publication Critical patent/BR0110184A/pt
Publication of BRPI0110184B1 publication Critical patent/BRPI0110184B1/pt
Publication of BRPI0110184B8 publication Critical patent/BRPI0110184B8/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/89—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members with hetero atoms directly attached to the ring nitrogen atom
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Abstract

"DERIVADO DE PIRIDINA-1-óXIDO, E PROCESSO PARA A SUA TRANSFORMAçãO EM COMPOSTOS FARMACEUTICAMENTE EFICAZES". A presente invenção refere-se a N-[2-hidróxi-3-(1-piperidinil)propóxi] piridina-1-óxido-3-carboxamidina e os enantiómeros oticamente ativos do mesmo. (R)-(-)-N-[2-hidróxi-3- (1-piperidinil) propóxi] piridina-1-óxido-3-carboxamidina e (S)-(+)-N- [2-hidróxi-3-(1-piperidinil) propóxi] piridina-1-óxido-3-carboxamidina. Ademais, a presente invenção refere-se à preparação de cloreto de N-[2-hidróxi-3-(1-piperidinil)propóxi] piridina-1-óxido-3-carboxamidina, que pode ser usado como um ingrediente ativo de medicamentos, e a preparação dos enantiómeros oticamente ativos do composto ao usar os compostos da presente invenção como substâncias intermediárias.
BRPI0110184A 2000-04-18 2001-04-17 derivado de piridina-1-óxido, e processo para a sua transformação em compostos farmaceuticamente eficazes BRPI0110184B8 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
HU0001583A HUP0001583A2 (hu) 2000-04-18 2000-04-18 Egy piridin-1-oxid-származék és eljárás annak átalakítására gyógyászati hatású vegyületekké
PCT/HU2001/000046 WO2001079174A1 (en) 2000-04-18 2001-04-17 A pyridine-1-oxide derivative, and process for its transformation into pharmaceutically effective compounds

Publications (3)

Publication Number Publication Date
BR0110184A true BR0110184A (pt) 2003-06-17
BRPI0110184B1 BRPI0110184B1 (pt) 2015-12-29
BRPI0110184B8 BRPI0110184B8 (pt) 2021-05-25

Family

ID=90001563

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0110184A BRPI0110184B8 (pt) 2000-04-18 2001-04-17 derivado de piridina-1-óxido, e processo para a sua transformação em compostos farmaceuticamente eficazes

Country Status (32)

Country Link
US (1) US7126002B2 (pt)
EP (1) EP1274685B1 (pt)
JP (1) JP5066638B2 (pt)
KR (1) KR100742482B1 (pt)
CN (1) CN1216868C (pt)
AT (1) ATE332894T1 (pt)
AU (2) AU2001254997B2 (pt)
BG (1) BG65889B1 (pt)
BR (1) BRPI0110184B8 (pt)
CA (1) CA2406266C (pt)
CY (1) CY1107473T1 (pt)
CZ (1) CZ301576B6 (pt)
DE (1) DE60121431T2 (pt)
DK (1) DK1274685T3 (pt)
EE (1) EE05085B1 (pt)
ES (1) ES2267758T3 (pt)
HK (1) HK1055741A1 (pt)
HR (1) HRP20020825A2 (pt)
HU (1) HUP0001583A2 (pt)
IL (2) IL152337A0 (pt)
MX (1) MXPA02010320A (pt)
NO (1) NO323535B1 (pt)
NZ (1) NZ522017A (pt)
PL (1) PL359826A1 (pt)
PT (1) PT1274685E (pt)
RS (1) RS51003B (pt)
RU (1) RU2281282C2 (pt)
SI (1) SI1274685T1 (pt)
SK (1) SK287606B6 (pt)
UA (1) UA75353C2 (pt)
WO (1) WO2001079174A1 (pt)
ZA (1) ZA200208460B (pt)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HUP9900475D0 (en) * 1999-02-26 1999-04-28 Biorex Kutato Fejlesztoe Kft O-(3-piperidino-2-hydroxy-1-propyl)-hiyroximic acid-halogenid derivative, it's use for treating insulin resistance, and pharmaceutical compositions containing them as active component
HU0103939D0 (en) * 2001-09-27 2001-11-28 Biorex Kutato Fejlesztoe Kft Pharmaceutical composition containing methformin and n-[2-hydroxy-3-(1-piperidinyl)-propoxy]-pyridine-1-oxide-3-carboximidoyl chloride
NZ533795A (en) * 2002-01-11 2006-03-31 Biorex Kutato Fejlesztoe Kft Carboxamidine derivatives and their use in the treatment of vascular diseases
HUP0303584A3 (en) 2003-10-30 2009-12-28 Cytrx Corp Use of a hydroximic acid halide derivative in the treatment of neurodegenerative diseases
WO2008039514A1 (en) * 2006-09-26 2008-04-03 Cytrx Corporation Pharmaceutical compositions and methods for treating diseases associated with neurodegeneration
CA2728363C (en) 2008-06-26 2019-02-19 Orphazyme Aps Use of hsp70 as a regulator of enzymatic activity
AU2011335545A1 (en) 2010-11-30 2013-06-13 Orphazyme Aps Methods for increasing intracellular activity of Hsp70
HUP1100535A2 (en) 2011-09-26 2013-04-29 Bracelia Invest Ltd Pharmaceutical composition for enhancement of stem cell treatment
HUP1100534A2 (en) 2011-09-26 2013-04-29 Balazs Dr Hazay Pharmaceutical composition for the treatment of muscle atrophy
PT3193840T (pt) 2014-09-15 2021-08-10 Orphazyme Aps Formulação de arimoclomol
EP3442530A1 (en) 2016-04-13 2019-02-20 Orphazyme A/S Heat shock proteins and cholesterol homeostasis
KR102254140B1 (ko) 2016-04-29 2021-05-24 오르파짐 에이/에스 글루코세레브로시다제 연관 장애를 치료하기 위한 아리모클로몰
HUP1800298A1 (hu) 2018-08-30 2020-05-28 N Gene Res Laboratories Inc Gyógyszerkombináció béta-receptor blokkolók hatásának módosítására és a mellékhatások csökkentésére
IL299250A (en) 2020-06-24 2023-02-01 Kempharm Denmark As Arimoclomol for the treatment of Gaucher disease
EP4247792A1 (en) * 2020-11-19 2023-09-27 Zevra Denmark A/S Processes for preparing arimoclomol citrate and intermediates thereof
EP4267139A1 (en) 2020-12-24 2023-11-01 Zevra Denmark A/S Arimoclomol for the treatment of niemann pick disease, type c, in patients with er type missense mutations

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HU207988B (en) * 1988-10-20 1993-07-28 Biorex Kutato Fejlesztoe Kft Process for producing halogenides of o-/3-amino-2-hydroxy-propyl/hydroximic acid and pharmaceutical compositions containing them as active components
HU9502843D0 (en) 1995-09-29 1995-11-28 Livigene Ltd Pharmaceutical composition
HU222994B1 (hu) * 1995-11-02 2004-01-28 BIOREX Kutató és Fejlesztő Rt. Hidroxilaminszármazékok és azok alkalmazása sejtek molekuláris chaperon-termelésének fokozására alkalmas gyógyszerkészítmények előállítására
HUP9900475D0 (en) * 1999-02-26 1999-04-28 Biorex Kutato Fejlesztoe Kft O-(3-piperidino-2-hydroxy-1-propyl)-hiyroximic acid-halogenid derivative, it's use for treating insulin resistance, and pharmaceutical compositions containing them as active component

Also Published As

Publication number Publication date
IL152337A (en) 2007-10-31
KR100742482B1 (ko) 2007-07-25
DE60121431D1 (de) 2006-08-24
DK1274685T3 (da) 2006-11-06
UA75353C2 (en) 2006-04-17
EE200200591A (et) 2004-04-15
ES2267758T3 (es) 2007-03-16
CZ301576B6 (cs) 2010-04-21
NO20025015D0 (no) 2002-10-18
YU78302A (sh) 2005-09-19
MXPA02010320A (es) 2004-09-06
AU2001254997B2 (en) 2006-11-23
CZ20023445A3 (cs) 2003-03-12
CN1434800A (zh) 2003-08-06
CY1107473T1 (el) 2012-12-19
RS51003B (sr) 2010-10-31
EE05085B1 (et) 2008-10-15
JP2004501080A (ja) 2004-01-15
JP5066638B2 (ja) 2012-11-07
SK287606B6 (sk) 2011-03-04
SI1274685T1 (sl) 2006-10-31
WO2001079174A8 (en) 2002-12-27
US7126002B2 (en) 2006-10-24
CA2406266C (en) 2010-07-20
BRPI0110184B8 (pt) 2021-05-25
KR20030011309A (ko) 2003-02-07
HUP0001583D0 (en) 2000-06-28
BRPI0110184B1 (pt) 2015-12-29
ZA200208460B (en) 2003-10-20
SK15082002A3 (sk) 2003-05-02
WO2001079174A1 (en) 2001-10-25
HK1055741A1 (en) 2004-01-21
PT1274685E (pt) 2006-09-29
US20040006232A1 (en) 2004-01-08
RU2002130710A (ru) 2004-03-20
NO323535B1 (no) 2007-06-04
PL359826A1 (en) 2004-09-06
EP1274685B1 (en) 2006-07-12
DE60121431T2 (de) 2007-01-18
NZ522017A (en) 2004-06-25
HUP0001583A2 (hu) 2002-11-28
CN1216868C (zh) 2005-08-31
HRP20020825A2 (en) 2004-12-31
ATE332894T1 (de) 2006-08-15
BG107199A (bg) 2003-07-31
BG65889B1 (bg) 2010-04-30
CA2406266A1 (en) 2001-10-25
NO20025015L (no) 2002-12-16
EP1274685A1 (en) 2003-01-15
AU5499701A (en) 2001-10-30
IL152337A0 (en) 2003-05-29
RU2281282C2 (ru) 2006-08-10

Similar Documents

Publication Publication Date Title
BR0110184A (pt) Derivado de piridina-1-óxido, e processo para a sua transformação em compostos farmaceuticamente eficazes
BR0213040A (pt) Composto, processo para preparar um composto, e, método de tratar doenças
BR0111116A (pt) Imitadores de trombopoietina
BR0108893A (pt) Composição farmacêutica, composto e processo de preparação de compostos
BR9908545A (pt) Derivado de piperidina, processo para a preparação do mesmo, composto, processo para a preparação do mesmo, e, composição farmacêutica
BR0114576A (pt) Composto, composição farmacêutica, uso de um composto, método de tratar um estado doentio e processo para preparar um composto
BR0116084A (pt) Amidas de ácido furanocarboxìlico e tiofenocarboxìlico ariladas com efeito bloqueador de canal de potássio
UY27548A1 (es) Sales de ácido succínico de 5,7,14-triazatetraciclo (10.3.1.02.11.04,9) exadeca-2 (11),3,5,7,9-pentaeno y composiciones farmacéuticas
AR019496A1 (es) Azalidas de 13 miembros, composiciones farmaceuticas, uso en la preparacion de medicamentos y preparacion de los mismos
BRPI0409498A (pt) uso de um composto, formulação farmacêutica, composto, composição farmacêutica, e, processo para preparação de um composto
PT839041E (pt) Sais de derivados de amidina e de inibidor de ciclooxigenase processo para a sua preparacao sua utilizacao como farmacos e composicoes farmaceuticas contendo os referidos sais
BR9814498A (pt) Processo para o tratamento de obesidade em um humano necessitando de tal tratamento, composto, uso do mesmo, produto, e, composição farmacêutica
PT1194415E (pt) Novos derivados da piperazinil-alquil-tiopirimidina composicoes farmaceuticas que os contem e um processo de preparacao da substancia activa
PT748314E (pt) Derivados tetrassubstituidos do imidazol, processo para a sua preparacao, sua utilizacao como medicamentos e composicoes farmaceuticas que os incorporam
BR1100524A (pt) Compostos, processo para sua preparação; compostos intermediários para os mesmos, e composições farmacêuticas
BR9705456A (pt) Compostos heterocìclicos, processo de aminometila para sua preparação e composições farmacêuticas que os contêm.
CA2203463A1 (fr) Nouveaux acides et esters de la diosmetine, et les compositions pharmaceutiques les contenant
BR9804485A (pt) Compostos de indanol, processo para sua preparação e composições farmacêuticas contendo os mesmos.
BR0115506A (pt) Composições farmacêuticas tendo uma ação antidiabética, e processo para sua preparação
MXPA05009763A (es) 2-(butil-1-sulfonilamino)-n-[1 (r)-(6-metoxipiridin-3-il) propil] benzamida, su uso en forma de un farmaco y preparaciones farmaceuticas que contienen a dicho compuesto.
BR9713587A (pt) Derivados de ácido 4-(1-piperazinil) benzóico, processo para preparação dos mesmos e suas aplicações terapêuticas
DK0863752T3 (da) Anvendelse af alkylaminderivater såsom terbinafin ved fremstillingen af et lægemiddel til behandling af ledsagende sygdomme af en helicobacter pylori-infektion.
BR9808574A (pt) Processo para a fabricação de um composto racêmico, composto, e, intermediários dos produtos preparados.
CA2235053A1 (fr) Nouveaux composes amines du 6,7,8,9-tetrahydro-cyclopenta¬a|naphtalene et du 2,3-dihydro-cyclopenta, ¬e|indene, leur procede de preparation et les compositions pharmaceutiques quiles contiennent
BR0306149A (pt) Composto, processo para a preparação do mesmo, composição farmacêutica, e, usos do composto, e de um inibidor de enzima degradadora da neurotensina

Legal Events

Date Code Title Description
B25A Requested transfer of rights approved

Owner name: CYTRX CORPORATION (US)

Free format text: TRANSFERIDO DE: BIOREX KUTATO ES FEJLESZTO RT

B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]
B25A Requested transfer of rights approved

Owner name: ORPHAZYME APS (DK)

B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: PAGAR RESTAURACAO.

B08H Application fees: decision cancelled [chapter 8.8 patent gazette]

Free format text: REFERENTE RPI 2308 DE 31/03/2014 (COD. 8.6)

B07E Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette]

Free format text: NOTIFICACAO DE ANUENCIA RELACIONADA COM O ART 229 DA LPI

B09A Decision: intention to grant [chapter 9.1 patent gazette]
B16A Patent or certificate of addition of invention granted [chapter 16.1 patent gazette]

Free format text: PRAZO DE VALIDADE: 10 (DEZ) ANOS CONTADOS A PARTIR DE 29/12/2015, OBSERVADAS AS CONDICOES LEGAIS.

B25D Requested change of name of applicant approved
B16C Correction of notification of the grant [chapter 16.3 patent gazette]

Free format text: PRAZO DE VALIDADE: 20 (VINTE) ANOS CONTADOS A PARTIR DE 17/04/2001 OBSERVADAS AS CONDICOES LEGAIS. PATENTE CONCEDIDA CONFORME ADI 5.529/DF

B21A Patent or certificate of addition expired [chapter 21.1 patent gazette]

Free format text: PATENTE EXTINTA EM 17/04/2021